Medical section

Fang Sheng (Beijing) International Bio-Technology Co., Ltd. (8143.HK) is a US listed investment holding group company, and is committed to US listed companies engaged in medical investment and hospital management in mainland China and overseas. Through capital leverage, the company actively introduces advanced medical technologies, management models and service concepts from abroad, combines the development status of the domestic medical industry, and provides diversification for the market through mergers and acquisitions cooperation, management consulting, special planning, professional training, and entrusted management. The hospital management and management solution aims to establish Fangsheng Medical as the preferred brand of hospital management and management in China.